Research
Hormonal
A well-designed vegan diet is an effective first-line treatment for Type 2 Diabetes, improving glycemia, insulin sensitivity, and beta-cell function.
Adopt a well-designed vegan diet to manage Type 2 Diabetes. This approach can significantly improve blood sugar control, insulin sensitivity, and beta-cell function, often more effectively than conventional diabetes diets.
GoodSupportsHIGH confidence
In addition, it has been demonstrated that with regard to diabetes type 2 outcomes, a well-designed vegan diet in short- and long-term settings has the greatest success compared to a controlled diet and other dietary interventions [67,114–118].
Why this rating
Supported by RCTs and meta-analyses cited in the review.
Source
Placing a Well-Designed Vegan Diet for Slovenes
Boštjan Jakše · Nutrients · 2021
DOI 10.3390/nu13124545
narrative_reviewCited 20×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- A well-designed vegan diet, supplemented with Vitamin B12 and Vitamin D, is safe, nutritionally adequate, and effective for maintaining or improving health in the general adult population.Good
- A well-designed vegan diet is effective for reducing body mass and improving body composition in overweight or obese adults, particularly when combined with physical activity.Good
- A well-designed vegan diet significantly reduces cardiovascular disease risk factors, including LDL cholesterol, triglycerides, and blood pressure, and can reverse coronary atherosclerosis.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →